ARACHIDONIC-ACID METABOLITES MODULATE RAT HYPOTHALAMIC CORTICOTROPIN-RELEASING HORMONE-SECRETION INVITRO

被引：89

作者：

BERNARDINI, R

CHIARENZA, A

CALOGERO, AE

GOLD, PW

CHROUSOS, GP

机构：

[1] NICHHD,DEV ENDOCRINOL BRANCH,BETHESDA,MD

[2] NIMH,CLIN NEUROENDOCRINOL BRANCH,BETHESDA,MD 20205

来源：

NEUROENDOCRINOLOGY | 1989年 / 50卷 / 06期

关键词：

D O I：

10.1159/000125303

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：708 / 715

页数：8

共 59 条

[1] PROSTAGLANDIN-F2-ALPHA AND THE THROMBOXANE A2 ANALOG ONO-11113 STIMULATE CA-2+ FLUXES AND OTHER PHYSIOLOGICAL-RESPONSES IN RAT-LIVER - FURTHER EVIDENCE THAT PROSTANOIDS MAY BE INVOLVED IN THE ACTION OF ARACHIDONIC-ACID AND PLATELET-ACTIVATING FACTOR [J].

ALTIN, JG ;

BYGRAVE, FL .

BIOCHEMICAL JOURNAL, 1988, 249 (03) :677-685

[2] CORTICOTROPIN-RELEASING FACTOR PRODUCING NEURONS IN THE RAT ACTIVATED BY INTERLEUKIN-1 [J].

BERKENBOSCH, F ;

VANOERS, J ;

DELREY, A ;

TILDERS, F ;

BESEDOVSKY, H .

SCIENCE, 1987, 238 (4826) :524-526

[3]

BERNARDINI R, 1988, NEW TRENDS BRAIN FEM, P35

[4]

BERNARDINI R, IN PRESS ENDOCRINOLO

[5] EFFECTS OF SEROTONERGIC AGONISTS AND ANTAGONISTS ON CORTICOTROPIN-RELEASING HORMONE-SECRETION BY EXPLANTED RAT HYPOTHALAMI [J].

CALOGERO, AE ;

BERNARDINI, R ;

MARGIORIS, AN ;

BAGDY, G ;

GALLUCCI, WT ;

MUNSON, PJ ;

TAMARKIN, L ;

TOMAI, TP ;

BRADY, L ;

GOLD, PW ;

CHROUSOS, GP .

PEPTIDES, 1989, 10 (01) :189-200

[6] MULTIPLE FEEDBACK REGULATORY LOOPS UPON RAT HYPOTHALAMIC CORTICOTROPIN-RELEASING HORMONE-SECRETION - POTENTIAL CLINICAL IMPLICATIONS [J].

CALOGERO, AE ;

GALLUCCI, WT ;

GOLD, PW ;

CHROUSOS, GP .

JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (03) :767-774

[7]

CALOGERO AE, 1989, ADV EXP BIOL MED, V245, P167

[8] DIRECT EVIDENCE OF A ROLE FOR MAST-CELLS IN THE PATHOGENESIS OF ANTIGEN-INDUCED BRONCHOCONSTRICTION [J].

CASALE, TB ;

WOOD, D ;

RICHERSON, HB ;

ZEHR, B ;

ZAVALA, D ;

HUNNINGHAKE, GW .

JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (05) :1507-1511

[9] ANALYSIS OF PROSTAGLANDIN-E2 EFFECT ON LYMPHOCYTE-T ACTIVATION - ABROGATION OF PROSTAGLANDIN-E2 INHIBITORY EFFECT BY THE TUMOR PROMOTOR 12.0 TETRADECANOYL PHORBOL-13 ACETATE [J].

CHOUAIB, S ;

ROBB, RJ ;

WELTE, K ;

DUPONT, B .

JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (02) :333-340

[10] CLINICAL-APPLICATIONS OF CORTICOTROPIN-RELEASING FACTOR [J].

CHROUSOS, GP ;

SCHUERMEYER, TH ;

DOPPMAN, J ;

OLDFIELD, EH ;

SCHULTE, HM ;

GOLD, PW ;

LORIAUX, DL .

ANNALS OF INTERNAL MEDICINE, 1985, 102 (03) :344-358

← 1 2 3 4 5 6 →